0001600132-19-000125.txt : 20190930 0001600132-19-000125.hdr.sgml : 20190930 20190930164822 ACCESSION NUMBER: 0001600132-19-000125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190926 FILED AS OF DATE: 20190930 DATE AS OF CHANGE: 20190930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT MATTHEW CENTRAL INDEX KEY: 0001267642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 191126515 MAIL ADDRESS: STREET 1: 227 WASHINGTON ST STREET 2: STE 200 CITY: CONSHONHOEKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_156987648053415.xml FORM 4 X0306 4 2019-09-26 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001267642 BENNETT MATTHEW C/O NEW MOUNTAIN CAPITAL, L.L.C. 787 SEVENTH AVENUE, 49TH FLOOR NEW YORK NY 10019 1 0 0 0 Stock Option (right to buy) 0.5 2019-09-26 4 A 0 46266 0 A 2020-09-26 2029-09-26 Common Stock 46266.0 84482 D Matthew Bennett 2019-09-30